SCHEMBL9293271

SCHEMBL9293271

NC(=S)NNS(N)(=O)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL328916 0.79 ALDH1A1 (0.43)
SCHEMBL2300730 0.78
SCHEMBL4956404 0.77
Ammonia Solution, Strong SCHEMBL28267901 0.76 ALDH1A1 (0.45)
SCHEMBL9293266 0.76
SCHEMBL28571254 0.76
SCHEMBL2301513 0.74
SCHEMBL28421938 0.74 ALDH1A1 (0.43)
SCHEMBL438395 0.67
SCHEMBL4335791 0.67 CA1 (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5308857-A Antiulcer agents FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1994-05-03 US claimed
EP-0355612-B1 Furylthiazole derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same FUJISAWA PHARMACEUTICAL CO (JP) 1994-07-27 EP disclosed
US-5308857-A Antiulcer agents FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1994-05-03 US disclosed
EP-0355612-A2 Furylthiazole derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1990-02-28 EP disclosed